Patent Assignment
Reel/Frame 062264/0846
Merger
Recorded: 2023-01-03
Pages: 6
Assignor
MERCK SHARP & DOHME CORP.
Executed: 2022-04-07
Assignee
MERCK SHARP & DOHME LLC
126 EAST LINCOLN AVENUE, RY86-2011A, RAHWAY, NEW JERSEY, 07065
Covered Properties
(2)
Combination of a Pd-1 Antagonist and Cpg-C Type Oligonucleotide for Treating Cancer
Combination of a Pd-1 Antagonist and Cpg-C Type Oligonucleotide for Treating Cancer
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 8, 2018
From: YU, YING; DENKER, ANDREW EVAN; SADEKOVA, SVETLANA; PHAN, UYEN TRUONG
To: MERCK SHARP & DOHME CORP.; DYNAVAX TECHNOLOGIES CORPORATION
Reel/Frame 046328/0007 →
Assignment of Assignor's Interest
Oct 14, 2020
From: DYNAVAX TECHNOLOGIES CORPORATION
To: SUREFIRE MEDICAL, INC. D/B/A TRISALUS LIFE SCIENCES
Reel/Frame 054057/0158 →
Assignment of Assignor's Interest
Nov 4, 2020
From: YU, YING; DENKER, ANDREW EVAN; SADEKOVA, SVETLANA; PHAN, UYEN TRUONG
To: MERCK SHARP & DOHME CORP.; DYNAVAX TECHNOLOGIES CORPORATION
Reel/Frame 054299/0756 →
Assignment of Assignor's Interest
Dec 15, 2020
From: DYNAVAX TECHNOLOGIES CORPORATION
To: SUREFIRE MEDICAL, INC. D/B/A TRISALUS LIFE SCIENCES
Reel/Frame 054646/0615 →
Change of Name
Oct 27, 2021
From: SUREFIRE MEDICAL, INC. D/B/A TRISALUS LIFE SCIENCES
To: TRISALUS LIFE SCIENCES, INC.
Reel/Frame 057943/0686 →
Security Interest
Apr 30, 2024
From: TRISALUS LIFE SCIENCES, INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP
Reel/Frame 067274/0733 →